JPMORGAN CHASE & CO - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 91 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$213,273
-30.2%
31,927
-12.4%
0.00%
Q2 2023$305,656
+30465.6%
36,431
+49805.5%
0.00%
Q1 2023$1,000
+99900.0%
730.0%0.00%
Q4 2022$173
-21.5%
0.00%
Q3 2022$093
+27.4%
0.00%
Q2 2022$0
-100.0%
73
-99.7%
0.00%
Q1 2022$101,000
+34.7%
22,835
+21.3%
0.00%
Q4 2021$75,000
-52.5%
18,823
+4.6%
0.00%
Q3 2021$158,000
-25.1%
17,991
-3.6%
0.00%
Q2 2021$211,000
+21000.0%
18,670
+38795.8%
0.00%
Q1 2021$1,000480.0%0.00%
Q4 2020$0480.0%0.00%
Q3 2020$0
-100.0%
48
-98.6%
0.00%
Q2 2020$14,000
-91.0%
3,429
-94.6%
0.00%
Q1 2020$156,000
+262.8%
63,340
+756.6%
0.00%
Q4 2019$43,000
-76.2%
7,394
-78.5%
0.00%
Q3 2019$181,000
+376.3%
34,323
+454.0%
0.00%
Q2 2019$38,000
-19.1%
6,195
+20.2%
0.00%
Q1 2019$47,000
-76.5%
5,154
-78.5%
0.00%
Q4 2018$200,000
+102.0%
24,020
+232.6%
0.00%
Q3 2018$99,000
-80.3%
7,221
-88.6%
0.00%
Q2 2018$503,000
+12.8%
63,296
+6.4%
0.00%
Q1 2018$446,000
+32.0%
59,502
+19.8%
0.00%
Q4 2017$338,000
+5533.3%
49,676
+4416.0%
0.00%
Q1 2017$6,000
-45.5%
1,100
-21.4%
0.00%
Q3 2016$11,000
+1000.0%
1,400
+600.0%
0.00%
Q2 2016$1,000
-99.7%
200
-99.7%
0.00%
Q3 2015$371,00063,6050.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders